Publicaciones en las que colabora con Manel Esteller Badosa (8)

1999

  1. Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation

    American Journal of Clinical Pathology, Vol. 111, Núm. 3, pp. 336-342

  2. Endometrial carcinoma in tamoxifen-treated breast cancer patient: Clinicopathological, immunohistochemical, and genetic analysis

    International Journal of Gynecological Pathology, Vol. 18, Núm. 4, pp. 387-391

1997

  1. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart

    Laboratory Investigation, Vol. 76, Núm. 1, pp. 109-116

  2. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility

    Carcinogenesis, Vol. 18, Núm. 12, pp. 2307-2311

  3. Susceptibility to endometrial cancer: Influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci

    British Journal of Cancer, Vol. 75, Núm. 9, pp. 1385-1388

  4. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer

    European Journal of Cancer, Vol. 33, Núm. 10, pp. 1572-1577

1995

  1. Detection of c‐erbB‐2/neu and fibroblast growth factor‐3/INT‐2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction

    Cancer, Vol. 75, Núm. 8, pp. 2139-2146

  2. High rate of MDR‐1 and heterogeneous pattern of MRP expression without gene amplification in endometrial cancer

    International Journal of Cancer, Vol. 63, Núm. 6, pp. 798-803